Paul Burton

The following is a transcript of an interview with Dr. Paul Burton, chief medical officer at Moderna, that aired Sunday, May 1, 2022, on "Face the Nation." MARGARET BRENNAN: Last week, Moderna asked the FDA to authorize its vaccine for children under the age of six. The company's chief medical officer, Dr. Paul Burton, joins us now from Princeton, New Jersey. Doctor, welcome to FACE THE NATION.

Maureen needed some assistance getting across the street in downtown Framingham during the snow storm Friday. So Paul Burton stepped in to help.

Paul P. Burton, CEO of Mastech InfoTrellis Inc., a data and analytics subsidiary of Pittsburgh-based Mastech Digital Inc. (NYSE: MHH), is leaving his post effective Dec. 14, according to a regulatory filing. Burton is resigning to pursue another business opportunity, the filing said. He first joined the company in April...

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here. Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Paul Burton, M.D., Ph.D., F.A.C.C, M.R.C.S will join the Company as Chief Medical Officer, effective July 6, 2021. He will serve on Moderna's Executive Committee and report to Chief Executive Officer Stéphane Bancel.